Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes
Author(s) -
Rebecca Bailey,
Jason D. Cooper,
Lauren R Zeitels,
Deborah J. Smyth,
Jennie H. M. Yang,
Neil Walker,
Elina Hyppönen,
David B. Dunger,
Elizabeth RamosLopez,
Klaus Badenhoop,
Sergey Nejentsev,
John A. Todd
Publication year - 2007
Publication title -
diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.219
H-Index - 330
eISSN - 1939-327X
pISSN - 0012-1797
DOI - 10.2337/db07-0652
Subject(s) - type 2 diabetes , vitamin d and neurology , endocrinology , medicine , diabetes mellitus , association (psychology) , biology , psychology , psychotherapist
Epidemiological studies have linked vitamin D deficiency with the susceptibility to type 1 diabetes. Higher levels of the active metabolite 1 alpha,25-dihydroxyvitamin D (1 alpha,25(OH)(2)D) could protect from immune destruction of the pancreatic beta-cells. 1 alpha,25(OH)(2)D is derived from its precursor 25-hydroxyvitamin D by the enzyme 1 alpha-hydroxylase encoded by the CYP27B1 gene and is inactivated by 24-hydroxylase encoded by the CYP24A1 gene. Our aim was to study the association between the CYP27B1 and CYP24A1 gene polymorphisms and type 1 diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom